Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2012
12/26/2012CN102838532A Novel compounds for a treatment of diseases associated with amyloid or amyloid-like proteins
12/26/2012CN102836347A Traditional Chinese medicine for treating tinnitus
12/26/2012CN102836316A Chinese medicine preparation for treating amblyopia
12/26/2012CN102836291A Traditional Chinese medicine decoction for preventing and treating pinkeye
12/26/2012CN102836229A Chinese medicinal composition for treating acute epidemic conjunctivitis
12/26/2012CN102836228A Chinese medicinal composition for treating conjunctivitis and preparation method and application thereof
12/26/2012CN102836211A Salvia miltiorrhiza-lobed kudzuvine root eyesight improving in-situ gel
12/26/2012CN102836178A Externally-applied medicine for treating otitis media
12/26/2012CN102836175A Artificial bear bile
12/26/2012CN102836124A Dibazol hydrochloride eye drops and preparation method thereof
12/26/2012CN102188523B Plant antibiotic
12/26/2012CN102038638B 盐酸克林霉素注射液及其制备方法 Clindamycin Hydrochloride Injection and its preparation method
12/26/2012CN101897975B Chitosan-Math1 gene nanoparticle and preparation method thereof
12/26/2012CN101804047B Antimicrobial and radioprotective compounds
12/26/2012CN101772345B A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol
12/26/2012CN101553214B Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
12/26/2012CN101210051B Anti-VEGF antibodies
12/26/2012CN101139392B KDR peptides and vaccines containing the same
12/26/2012CN100998864B Cyclosporin A semisolid skeleton capsule
12/25/2012US8338421 Compositions and methods for reversing rebound hyperemia
12/25/2012US8338384 Method for treating ocular neovascularization
12/25/2012US8337834 Methods of making enhanced, autologous fat grafts
12/25/2012US8337829 Conditioned medium and proliferated cell lines produced therefrom
12/20/2012WO2012174243A1 D -serine for the treatment of visual system disorders
12/20/2012WO2012173634A1 Systems and methods for balancing and maintaining the health of the human autonomic nervous system
12/20/2012WO2012173219A1 Novel biaryl ether derivative
12/20/2012WO2012173217A1 Crystal of pyrroloquinolinequinone disodium salt, and method for producing same
12/20/2012WO2012173207A1 Method of inducing differentiation to retina cells
12/20/2012WO2012173174A1 Azaspiroalkane compound
12/20/2012WO2012149329A3 Methods of predicting the development of complement-mediated disease
12/20/2012US20120323162 Methods and Compositions for Treating Conditions of the Eye
12/20/2012US20120322891 Retinoid replacements and opsin agonists and methods for the use thereof
12/20/2012US20120322887 Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation
12/20/2012US20120322877 (bis)urea and (bis)thiorea compounds as eipgenic modulators of lysine-specific demethylase 1 and methods of treating disorders
12/20/2012US20120322874 Pharmaceutical Uses
12/20/2012US20120322871 Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives
12/20/2012US20120322865 Sustained polypeptide expression from synthetic, modified rnas and uses thereof
12/20/2012US20120322829 Use of a dipyridyl compound for treating rosacea
12/20/2012US20120322825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
12/20/2012US20120322823 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
12/20/2012US20120322801 Heterocyclic amides as rock inhibitors
12/20/2012US20120322799 Deuterated compounds useful for treating neurodegenerative diseases
12/20/2012US20120322747 Beta-turn peptidomimetic cyclic compounds for treating dry eye
12/20/2012US20120322746 Methods, compositions, and kits for the treatment of ophthalmic disorders
12/20/2012US20120321721 Novel formulation of physiological chitosan-inorganic salt solution/blood mixtures for tissue repair
12/20/2012US20120321719 Sustained Delivery of Therapeutic Agents to an Eye Compartment
12/20/2012US20120321683 Liposome-Encapsulated Bicelles and Use Thereof in Diluted Systems
12/20/2012US20120321675 Methods of inhibiting cataracts and presbyopia
12/20/2012US20120321673 Transdermal drug delivery system and method of using the same
12/20/2012US20120321651 Anti-IGE Vaccines
12/20/2012US20120321594 Methods of controlling axon or dendrite development of neuronal cells
12/20/2012US20120321593 Low oxygen culture conditions for maintaining retinal progenitor cell multipotency
12/20/2012US20120321591 Anti-angiogenic compounds
12/20/2012US20120321585 Crosslinked Hydrogels and Related Method of Preparation
12/20/2012CA2839735A1 D-serine for the treatment of visual system disorders
12/19/2012EP2535051A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
12/19/2012EP2534139A1 Novel aminoalkyl-oxazole and aminoalkyl-thiazole carboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissue
12/19/2012CN102834384A Oxazine derivative
12/19/2012CN102827737A Health-care wine for clearing liver and improving eyesight
12/19/2012CN102827291A Recombinant fusion protein PTD-HSP27 and use thereof
12/19/2012CN102827253A Micro-molecular polypeptide inhibiting inflammatory response, and application thereof
12/19/2012CN102827228A Silicon phthalocyanine modified by cytidine derivative and preparation method and application thereof
12/19/2012CN102827227A Silicon phthalocyanine modified by adenosine derivative and preparation method and application thereof
12/19/2012CN102827226A Silicon phthalocyanine modified by uridine derivatives and preparation method and application of silicon phthalocyanine
12/19/2012CN102827167A Octahydro-pyrrolo[3,4-b]pyrrole derivatives and use of octahydro-pyrrolo[3,4-b]pyrrole derivatives as histamine-3 receptor
12/19/2012CN102827131A Isoflavone carbamate compound, preparation method and applications of isoflavone carbamate compound
12/19/2012CN102824644A High-stability sustained-release tablet prepared by using hydroxy propyl cellulose
12/19/2012CN102824548A Traditional Chinese medicine composition for treating asthenopia and preparation method thereof
12/19/2012CN102824547A Traditional Chinese medicine ultrasonic atomization agent for treating xerophthalmia and preparation method thereof
12/19/2012CN102824467A Drug for treating amblyopia
12/19/2012CN102824305A Azithromycin eye drops and preparation method thereof
12/19/2012CN102357243B Recombinant cattle basic fibroblastic growth factor eye drops
12/19/2012CN101926788B Cardiovascular/cerebral and ophthalmological medicines, and preparation and use thereof
12/19/2012CN101787063B Anti-infective medicament and preparation and application thereof
12/19/2012CN101759806B Cytoplasm leader peptide (CTD)-containing human epidermal growth factor fusion protein (CTD-hEGF) prepared by using hydroxylamine cutting method and application thereof
12/19/2012CN101115728B Triazole substituted aminobenzophenone compounds
12/18/2012US8334296 2,4-pyrimidinediamine compounds and their uses
12/18/2012CA2754102C Monoclonal antibodies and compositions comprising such useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/18/2012CA2719721C Tetrahydroisoquinoline derivative
12/13/2012WO2012169849A2 Eye-drop composition for preventing or treating ocular diseases
12/13/2012WO2012168435A1 Methods for the treatment of leber congenital amaurosis
12/13/2012US20120316380 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316243 Enhanced bimatoprost ophthalmic solution
12/13/2012US20120316226 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor
12/13/2012US20120316212 Amino alcohol derivatives and their therapeutic activities
12/13/2012US20120316198 Hydrazone and diacyl hydrazine compounds and methods of use
12/13/2012US20120316194 Apoptosis signal-regulating kinase 1 inhibitors
12/13/2012US20120316188 Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors
12/13/2012US20120316182 Compounds that modulate intracellular calcium
12/13/2012US20120316168 Quinolone compound and pharmaceutical composition
12/13/2012US20120316163 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316159 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
12/13/2012US20120316158 Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof
12/13/2012US20120316152 Substituted isoquinolineand isoquinolinone derivatives
12/13/2012US20120316148 Compositions and Methods for Modulating a Kinase
12/13/2012US20120316143 Ophthalmic composition
12/13/2012US20120316128 Citicoline for the treatment of glaucoma and ocular hypertension
12/13/2012US20120316112 Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein
12/13/2012US20120315288 LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY
12/13/2012US20120315285 Antibody Formulation
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 531